Inhibition of the CXCL 12/CXCR 4 chemokine axis with AMD 3100, a CXCR 4 small molecule inhibitor, worsens murine hepatic injury
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Aim: Activation of hepatic stellate cells and development of chronic inflammation are two key features in the progression of hepatic fibrosis. We have shown that in vitro activated stellate cells increase their expression of CXCL 12 as well as the receptor CXCR 4 and that receptor engagement promotes a profibrogenic phenotype. Furthermore, injury promotes increased hepatic expression of CXCL 12 and a massive infiltration of CXCR 4‐expressing leukocytes, granulocytes and myeloid cells. The primary site of inflammatory cell accumulation is around the CXCL 12‐rich portal tracts and within fibrotic septae, indicating a role for CXCR 4 during injury. In order to characterize the relevance of the CXCR 4/CXCL 12 chemokine axis during hepatic injury we inhibited the axis using AMD 3100, a CXCR 4 small molecule inhibitor, in models of chronic and acute liver injury. Methods: Mice were subjected to acute and chronic CC l 4 liver injury with and without AMD 3100 administration. The degree of liver injury, fibrosis and the composition of the intrahepatic inflammatory response were characterized. Results: Treatment of mice with AMD 3100 in the chronic CC l 4 model of liver injury led to an increase in hepatic inflammation and fibrosis with a specific increase in intrahepatic neutrophils. Furthermore, in an acute model of CC l 4‐induced liver injury, AMD 3100 led to an increase in the number of intrahepatic neutrophils and a trend towards worse necrosis. Conclusion: Together, this data suggests that inhibition of the CXCR 4/CXCL 12 chemokine axis is injurious through modulation of the hepatic inflammatory response and that this axis may serve a protective role in liver injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Karlmark, K. R., Weiskirchen, R., Zimmermann, H. W., Gassler, N., Ginhoux, F., Weber, C., Merad, M., Luedde, T., Trautwein, C., & Tacke, F. (2009) · Hepatology · doi:10.1002/hep.22950 · Cited by 782
CCR1 and CCR5 promote hepatic fibrosis in mice
Seki, E., De Minicis, S., Gwak, G.-Y., Kluwe, J., Inokuchi, S., Bursill, C. A., Llovet, J. M., Brenner, D. A., & Schwabe, R. F. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37444 · Cited by 431
Attenuated liver fibrosis in the absence of B cells
Novobrantseva, T. I. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24798 · Cited by 277
McCandless, E. E., Piccio, L., Woerner, B. M., Schmidt, R. E., Rubin, J. B., Cross, A. H., & Klein, R. S. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070918 · Cited by 206
Cited by
Cipriani, S., Carino, A., Masullo, D., Zampella, A., Distrutti, E., & Fiorucci, S. (2017) · Scientific Reports · doi:10.1038/srep41055 · Cited by 16
Nguyen, N. T., Umbaugh, D. S., Huang, E. L., Adelusi, O. B., Sanchez Guerrero, G., Ramachandran, A., & Jaeschke, H. (2022) · Toxicological Sciences · doi:10.1093/toxsci/kfac057 · Cited by 15
Jia, H., Ding, L., Yu, A., Tang, W., Tang, S., Zhang, C., & Oupický, D. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.07.018 · Cited by 12
Metadata
- Authors
- Saiman, Y., Jiao, J., Fiel, M. I., Friedman, S. L., Aloman, C., & Bansal, M. B.
- Venue
- Hepatology Research
- Publisher
- Wiley
- Published
- 2014-10-07
- Volume
- 45
- Issue
- 7
- Pages
- 794-803
- ISSN
- 1386-6346 (ISSN-L)
- 1872-034X
- OpenAlex
- W1951641979
- Cited by
- 40
- References
- 4
- FWCI
- 1.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.